/ /

  • linkedin
  • Increase Font
  • Sharebar

    Genes identify potential risk for AMD

    Orlando—Patients with 2 CFH risk alleles and no ARMS2 risk alleles would be better served by not taking the Age-Related Eye Disease Study (AREDS) formulation, according to Carl C. Awh, MD.

    Dr. Awh, Tennessee Retina, Nashville, said he observed outcomes of patients followed in the study to support published findings that show response to components of the AREDS formulation is influenced by CFH and ARMS2 alleles.

    DNA from white AREDS participants (989) with AREDS category 3 disease in at least one eye was genotyped at CFH and ARMS2 loci. Age-related macular degeneration progression was defined as development of AREDS category 4 disease in any eye with category 1 to 3 disease at study entry.

    Patients were divided into four groups based on relative higher or lower CFH and ARMS2 risk allele number.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results